176 related articles for article (PubMed ID: 16964708)
1. Rapid in vivo dissolution of ketoprofen: implications on the biopharmaceutics classification system.
Granero GE; Ramachandran C; Amidon GL
Pharmazie; 2006 Aug; 61(8):673-6. PubMed ID: 16964708
[TBL] [Abstract][Full Text] [Related]
2. Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188.
Fischer SM; Parmentier J; Buckley ST; Reimold I; Brandl M; Fricker G
J Pharm Pharmacol; 2012 Nov; 64(11):1631-7. PubMed ID: 23058050
[TBL] [Abstract][Full Text] [Related]
3. Possibility of enterohepatic recycling of ketoprofen in dogs.
Granero GE; Amidon GL
Int J Pharm; 2008 Feb; 349(1-2):166-71. PubMed ID: 17890028
[TBL] [Abstract][Full Text] [Related]
4. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
6. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic study of ketoprofen in rat by blood microdialysis technique].
He HB; Tang X; Cui FD
Yao Xue Xue Bao; 2006 May; 41(5):452-6. PubMed ID: 16848323
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the pharmacokinetic-pharmacodynamic model of ketoprofen beta-CD inclusion complex in rabbits].
Lu W; Tu X; Wu G
Yao Xue Xue Bao; 1998 Nov; 33(11):855-9. PubMed ID: 12016948
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bioequivalence after oral, intramuscular, and intravenous administration of racemic ketoprofen in pigs.
Raekallio MR; Mustonen KM; Heinonen ML; Peltoniemi OA; Säkkinen MS; Peltoniemi SM; Honkavaara JM; Vainio OM
Am J Vet Res; 2008 Jan; 69(1):108-13. PubMed ID: 18167095
[TBL] [Abstract][Full Text] [Related]
13. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
Cevc G; Mazgareanu S; Rother M
Int J Pharm; 2008 Aug; 360(1-2):29-39. PubMed ID: 18337027
[TBL] [Abstract][Full Text] [Related]
14. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
Wei H; Löbenberg R
Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
[TBL] [Abstract][Full Text] [Related]
15. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets.
Garcia-Arieta A; Gordon J; Gwaza L; Mangas-Sanjuan V; Álvarez C; Torrado JJ
Mol Pharm; 2015 Sep; 12(9):3194-201. PubMed ID: 26237401
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of racemic ketoprofen in healthy horses following rectal administration.
Corveleyn S; Henrist D; Remon JP; Van Der Weken G; Baeyens W; Haustraete J; Aboul-Enein HY; Sustronck B; Deprez P
Res Vet Sci; 1999 Oct; 67(2):203-4. PubMed ID: 10502494
[TBL] [Abstract][Full Text] [Related]
17. Intestinal absorption characteristics of ketoprofen in rats.
Choi JS; Jin MJ; Han HK
Biopharm Drug Dispos; 2006 Jan; 27(1):17-21. PubMed ID: 16278925
[TBL] [Abstract][Full Text] [Related]
18. Species comparison of enantioselective oral bioavailability and pharmacokinetics of ketoprofen.
Neirinckx E; Croubels S; De Boever S; Remon JP; Bosmans T; Daminet S; De Backer P; Vervaet C
Res Vet Sci; 2011 Dec; 91(3):415-21. PubMed ID: 20961590
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action.
Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY
Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483
[TBL] [Abstract][Full Text] [Related]
20. A perspective for biowaivers of human bioequivalence studies on the basis of the combination of the ratio of AUC to the dose and the biopharmaceutics classification system.
Sakuma S; Tachiki H; Uchiyama H; Fukui Y; Takeuchi N; Kumamoto K; Satoh T; Yamamoto Y; Ishii E; Sakai Y; Takeuchi S; Sugita M; Yamashita S
Mol Pharm; 2011 Aug; 8(4):1113-9. PubMed ID: 21630662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
